1. Safety, tolerability, pharmacokinetics, and immunological activity ... Sobieszczyk, Magdalena E.; Mannheimer, Sharon B.; Paez, Carmen A.; Yu, Chenchen; Gamble, Theresa; Theodore, Deborah Anne; Chege, Wairimu; Yacovone, Margaret; Hanscom, Brett; Heptinstall, Jack; Seaton, Kelly E.; Zhang, Lily; Miner, Maurine D.; Eaton, Amanda; Weiner, Joshua A.; Kalams, Spyros; Stephenson, Kathryn; Julg, Boris; Caskey, Marina; Nussenzweig, Michel; Gama, Lucio; Barouch, Dan H.; Ackerman, Margaret E.; Tomaras, Georgia D.; Montefiori, David; HVTN 130 HPTN 089 Study Team 2023 Articles Monoclonal antibodiesHIV infections—PreventionClinical trialsMedicine
2. Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans Soffer, Gissette; Pavlyha, Marianna; Ngai, Colleen I.; Thomas, Tiffany; Holleran, Stephen F.; Ramakrishnan, Rajasekhar; Karmally, Wahida; Nandakumar, Renu; Fontanez, Nelson; Obunike, Joseph; Marcovina, Santica M.; Lichtenstein, Alice H.; Matthan, Nirupa R.; Matta, James; Maroccia, Magali; Becue, Frederic; Poitiers, Franck; Swanson, Brian; Cowan, Lisa; Sasiela, William J.; Surks, Howard K.; Ginsberg, Henry N. 2017 Articles Lipoproteins--MetabolismProprotein convertasesLipoprotein AMonoclonal antibodiesMedicine
3. Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation Morales, Rita Elena; Shoushtari, Alexander N.; Walsh, Michelle M.; Grewal, Priya; Lipson, Evan J.; Carvajal, Richard Dale 2015 Articles Monoclonal antibodiesMetastasisImmunosuppressive agentsImmunology